APPLICATIONS PUBLISHED 25 SEPTEMBER 2002
Published: 1-Mar-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Modification of floral scent in flowering plants
Ball Horticultural Co 1241942*
Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same
Bayer 1241943*
Cancer immunotherapy and diagnosis using cytochrome P450 1B1
Dana-Farber Cancer Institute; Trustees of Boston University 1241945*
Improved transdermal contraceptive delivery system and process
Agile Therapeutics 1242012*
Oral transmucosal drug dosage using solid solution
Anesta Corp 1242013*
Fenifibrate galenic formulations and method for obtaining same
Fournier Industrie et Sante 1242047*
Inhalation particles
Orion Corp 1242048*
HLA class 1 A2 tumour associated antigen peptides and vaccine compsns
Epimmune 1242049*
Surviving promotion of angiogenesis
Yale University 1242050*
Novel forms of pravistatin sodium
Biogal Gyogyszergyar 1242051*
Histidine copolymer and methods for using same
Mixson, A James 1242052*
Apparatus and method for preparing microparticles using in-line solvent extraction
Alkermes Controlled Therapeutics 1242053*
Odour-masking coating for a pharmaceutical preparation
Ancile Pharmaceuticals 1242054*
Hydrogel-driven drug dosage form
Pfizer 1242055*
Use of a water-soluble agent containing polyglycerols for lubricating extrusions, in particular strips
Greither, Peter 1242056*
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
DepoMed 1242057*
Use of CYP2D6 inhibitors in combination therapies
Pfizer 1242058*
Novel prodrugs for antimicrobial amidines
University of North Carolina at Chapel Hill 1242059*
Treatment of metastatic disease
Purdue Research Foundation; Glaxo Group; University of North Carolina 1242060*
Use of bioactive metabolites of gepirone for the treatment of psychological disorder
Fabre/Kramer Pharmaceuticals 1242061*
Anhydrous gel comprising NSAID for administration into the oral cavity
Cosmo 1242062*
Compsns and methods for treatment of neurological disorders and neurodegenerative diseases
Massachusetts Institute of Technology 1242063*
Liver selective therapy
Howard J Smith and Associates 1242064*
New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist
AstraZeneca 1242065*
Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
Teva Pharmaceutical Industries 1242066*
Calcium formate for use as a phosphorus binder and a dietary supplement
Wisconsin Alumni Research Foundation 1242067*
Endogenous nitric oxide synthesis under conditions of low oxygen tension
Nitromed 1242068*
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
Exocell 1242069*
Treatment of ischaemic brain injuries with brain targeted antioxidant compounds
Yissum Research Development Company of the Hebrew University of Jerusalem; Mor-Research Applications; Ramot University for Applied Research and Industrial Development 1242070*
Use of parthenolide to inhibit cancer
Advanced Research and Technology Institute 1242071*
Antipsychotic heterocycle compounds
Bristol-Myers Squibb 1242072*
Compsns for prevention and treatment of cold and influenza-type symptoms and their means of use
Procter & Gamble 1242074*
5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/AR2B antagonists
Merck 1242074*
Indole compounds
SmithKline Beecham 1242075*
2-benzyl and 2-heteroalkyl benzimidazole NMDA/NR2B antagonists
Merck 1242076*
Novel process for making- and a new crystalline form of- leflunomide
Teva Pharmaceutical Industries 1242077*
Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats
AWD.pharma; Bayer 1242078*
Methods of use of fluoroquinolone compounds against bacteria
SmithKline Beecham 1242079*
Dopamine transporter inhibitors and their use
Georgetown University 1242080*
Caspases and apoptosis
SmithKline Beecham 1242081*
Methods and compsns for the prevention and treatment of atherosclerosis, restenosis and related disorders
Celgene Corp 1242082*
Phenoxypropanolamines, method for producing them and pharmaceutical compsns containing them
Sanofi-Synthelabo 1242083*
Treatment of lymphomas, leukaemias, breast carcinomas. astrcytomas, melanomas, leiomyomas, and related tumours
Margolin, Solomon 1242084*
Benzimidazole compounds having nociceptin receptor affinity
Euro-Celtique 1242085*
CD45 inhibitors
AstraZeneca 1242086*
Analgesic compsns containing buprenorphine
Reckitt Benckiser Healthcare 1242087*
Oral mucosal dosages of apomorphine
Tap Holdings 1242088*
Use of adatanserin for the treatment of neurodegenerative conditions
American Home Products 1242089*
Use of H1 antagonist and a safe steroid to treat eye conditions
Alcon 1242090*
Pharmaceutical compsns comprising oxcarbazepine
Novartis 1242091*
Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
Akzo Nobel 1242092*
A method of treating substance addiction
Shulman, Albert 1242093*
Methods for treating mild cognitive impairment
Corcept Therapeutics 1242094*
Antimicrobial compsns and methods of use
The Regents of the University of Michigan 1242095*
Combinations for the treatment of DNA viral infections comprising a loop diuretic and lithium
Henderson Morley Research and Development 1242096*
Pharmaceutical compsn comprising a vanadium compound and at least a component selected from a Na+/H+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
Gho'st Holding 1242097*
Aqueous ionic solutions and their use in particular in ophthalmology
Laboratoires Goemar 1242098*
A method of treating infectious diseases
Aruba International 1242099*
Regenerative adjuvant
Curasan 1242100*
Method for producing a bone material enriched with bone growth factors
Tutogen Medical 1232101*
Asthma/allergy therapy that targets T-lymphocytes and/or eosinphils
Al-jassim, Rawaa; Al-Kaisi, Ban; James, David; Nasseif, Nida Abdul-Ghani 1242102*
Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof
Cheil Jedang Corp 1242103*
Process of obtaining thylakoids from plants, pure thylakoids and use thereof
Purecell Technologies 1242104*
Combination of ginseng and ginkgo to improve cognitive skills
Pharmaton 1232105*
Carbon dioxide enhancement of inhalation therapy
Research Development Foundation 1242106*
Method for PR-39 peptide mediated selective inhibition of IKAPPABALPHA degradation
Beth Israel Deaconess Medical Centre 1243107*
Optimised minigenes and peptides encoded thereby
Epimmune 1242108*
A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide T
Advanced Immunit 1242109*
A method and compsn for treating prostate cancer
Immunolytics 1242110*
An animal model for studying hormone signalling and method of modulating the signalling
The Walter and Eliza Hall Institute of Medical Research 1242111*
Particulate drug-containing products and method of manufacture
Rxkinetix 1242112*
Methods and compsns for inhibiting adhesions by microorganisms
University of Louisville Research Foundation; Board of Trustees of Miami University 12432113*
Use of enzymes for skin expansion
Amir, Reva 1242114*
Chemically-programmable immunity
Mullis, Kary 1242115*
Herpes simplex virus-1 glycoprotein C mutans for treating unwanted hyperproliferative cell growth
Onyx Pharmaceuticals 1242116*
Methods of treating central nervous system ischaemic or haemorrhagic injury using anti-alpha4 integrin antagonists
Biogen 1242118*
Combinations for the treatment of DNA viral infections comprising a loop diuretic and a cardiac glycoside
Henderson Morley Research and Development 1242119*
Combinations of growth factors and I:UPA or I:MMP for the treatment of damaged tissue
Pfizer 1242120*
Polypeptide compsns with improved stability
Eli Lilly 1242121*
Delivery of proteins across polar epithelial cell layers
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services; Genentech 1242122*
Absorbing fat with chitosan
Vanson 1242123*
Polynucleotide vaccines expressing codon optimised HIV-1 POL and modified HIV-1 POL
Merck 1242124*
Microparticles based on aspartic acid and its use thereof as MRI contrast agents
Zotz, Rainer 1242125*
Device for diffusing aromas
Firmenich 1242126*
